Peter Josef Gust

Peter Gust practices at Southwest Skin and Vein Center in Austin, Texas.

Peter Gust's NPI, 1316488513, was assigned on March 20, 2017. Peter Gust graduated from Loma Linda University School Of Medicine in 2017. Peter Gust holds Texas license T1087.

Peter Gust's primary practice is Southwest Skin and Vein Center, at 4419 Frontier Trl, Austin, TX 78745 in Travis County. The practice phone is (512) 444-7208.

Peter Gust's primary practice is Southwest Skin and Vein Center in Austin, Texas. The medical group on file is Southwest Dermatology & Vein. Dmand AI also links Peter Gust to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Peter Gust practices. Vendor and product names are available with a free account.

Dermatology is Peter Gust's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Peter Gust is board certified in dermatology by the American Board of Dermatology. Dmand AI has Peter Gust's licenses on file in 2 states: Texas and California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, itchy rashes and minor injury to a limb among the conditions Peter Gust treats.

CMS data shows 1,215 Medicare services from Peter Gust across 11 procedure codes in 2024, for 209 Medicare patients. Medicare paid $45,883 for them. Every service was in an office.

CMS counts 209 Medicare patients who saw Peter Gust in 2024. The largest group is 65 to 74, with 107 patients. 68% of them have high cholesterol, and 64% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Peter Gust's median patient age at 61, with 50% women.

In 2024, Peter Gust wrote 530 Medicare Part D claims for 174 patients. 85% of them were for generic drugs. CMS names the drug for 445 of them, across 13 drugs with 11 or more claims each, at $201,164 in total drug cost. In 2023, CMS named 330 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Peter Gust for performance year 2024, reported as part of a group. Peter Gust accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 301 procedures of removal of skin lesions by Peter Gust, more than 82% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Peter Gust. Peter Gust's most frequent co-authors are Linda Golkar and Janna Mieko Vassantachart.

CMS Open Payments shows 82 general payments to Peter Gust from 14 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $397.

Peter Gust graduated from Loma Linda University School Of Medicine in 2017.

Peter Gust is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.